Daratumumab in Immune-mediated Thrombotic Thrombocytopenic Purpura

Abroad (travel likely)Recruiting

Conditions

Thrombotic Thrombocytopenic Purpura, Acquired

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, Milan, Italy
Contact: Study coordinator (Juri A Giannotta, M.D.) · juri.giannotta@policlinico.mi.it · +390255035273
Contact: Principal Investigator (Juri A Giannotta, M.D.)

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Association of TNFAIP3 With Immune-mediated TTP

Thrombotic Thrombocytopenic Purpura, Acquired

Abroad (travel likely)Recruiting

Milan, Italy

Longitudinal Cohort of Thrombosis and Hemostasis Diseases

Immune Thrombocytopenia · Thrombotic Thrombocytopenic Purpura · Hemophilia A, Acquired

Abroad (travel likely)Recruiting

Beijing, China · Beijing, China

Genotype and Phenotype Correlation in Hereditary Thrombotic Thrombocytopenic Purpura (Upshaw-Schulman Syndrome)

Thrombotic Thrombocytopenic Purpura · Congenital Thrombotic Thrombocytopenic Purpura · Familial Thrombotic Thrombocytopenic Purpura

Abroad (travel likely)Recruiting

Oklahoma City, United States · Vienna, Austria